GeneDx Reports Fourth Quarter and Full Year 2023 Financial R

Reported fourth quarter 2023 revenue from continuing operations1 of $58.1M with more than 68% year-over-year growth of exome and genome test revenue Expanded fourth quarter 2023 adjusted gross...

Related Keywords

Florida , United States , New York , Arizona , Utah , American , Katherine Stueland , American Epilepsy Society Annual Meeting , Globenewswire Inc , Google Health , Exchange Commission , Nasdaq , Twitter , Linkedin , Company Class , York Center , American College Of Medical Genetics , University Of Washington , Instagram , Facebook , Genedx Holdings Corp , Chief Executive Officer , Full Year , Legacy Sema , Legacy Genedx , Epilepsy Society Annual Meeting , Medical Genetics , Rare Diseases , Chief Growth Officer , Chief Product , Conference Call , Annual Report , Relations Contact , Select Financial Information , Markets ,